These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. An immunohistochemical study of primary signet-ring cell carcinoma of the stomach and colorectum: II. Expression of MUC1, MUC2, MUC5AC, and MUC6 in normal mucosa and in 42 cases. Terada T. Int J Clin Exp Pathol; 2013 Sep; 6(4):613-21. PubMed ID: 23573307 [Abstract] [Full Text] [Related]
3. [Expression and clinical significance of Mucin and E-cadherin in colorectal tumors]. Yu XW, Rong W, Xu FL, Xu GY, Sun YR, Feng MY. Ai Zheng; 2007 Nov; 26(11):1204-10. PubMed ID: 17991319 [Abstract] [Full Text] [Related]
4. Expression profile of mucins (MUC1, MUC2, MUC5AC, and MUC6) in ovarian mucinous tumours: changes in expression from benign to malignant tumours. Wang J, El-Bahrawy M. Histopathology; 2015 Mar; 66(4):529-35. PubMed ID: 25298197 [Abstract] [Full Text] [Related]
5. Human fetal ductal plate revisited: II. MUC1, MUC5AC, and MUC6 are expressed in human fetal ductal plate and MUC1 is expressed also in remodeling ductal plate, remodeled ductal plate and mature bile ducts of human fetal livers. Terada T. Int J Clin Exp Pathol; 2013 Mar; 6(4):571-85. PubMed ID: 23573304 [Abstract] [Full Text] [Related]
6. Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. Reis CA, David L, Correa P, Carneiro F, de Bolós C, Garcia E, Mandel U, Clausen H, Sobrinho-Simões M. Cancer Res; 1999 Mar 01; 59(5):1003-7. PubMed ID: 10070955 [Abstract] [Full Text] [Related]
7. Expression of MUC1, MUC2, MUC5AC and MUC6 in cholangiocarcinoma: prognostic impact. Park SY, Roh SJ, Kim YN, Kim SZ, Park HS, Jang KY, Chung MJ, Kang MJ, Lee DG, Moon WS. Oncol Rep; 2009 Sep 01; 22(3):649-57. PubMed ID: 19639217 [Abstract] [Full Text] [Related]
8. Immunohistochemical Expressions of MUC2, MUC5AC, and MUC6 in Normal, Helicobacter pylori Infected and Metaplastic Gastric Mucosa of Children and Adolescents. Park JS, Yeom JS, Seo JH, Lim JY, Park CH, Woo HO, Youn HS, Jun JS, Park JH, Ko GH, Baik SC, Lee WK, Cho MJ, Rhee KH. Helicobacter; 2015 Aug 01; 20(4):260-8. PubMed ID: 25704078 [Abstract] [Full Text] [Related]
9. Expression of mucins (MUC1, MUC2, MUC5AC and MUC6) in mucinous carcinoma of the breast: comparison with invasive ductal carcinoma. Matsukita S, Nomoto M, Kitajima S, Tanaka S, Goto M, Irimura T, Kim YS, Sato E, Yonezawa S. Histopathology; 2003 Jan 01; 42(1):26-36. PubMed ID: 12493022 [Abstract] [Full Text] [Related]
10. Differential mucin phenotypes and their significance in a variation of colorectal carcinoma. Imai Y, Yamagishi H, Fukuda K, Ono Y, Inoue T, Ueda Y. World J Gastroenterol; 2013 Jul 07; 19(25):3957-68. PubMed ID: 23840140 [Abstract] [Full Text] [Related]
11. Immunohistochemical evaluation of mucin expression in precancerous tissue of stomach. Vernygorodskyi S. Exp Oncol; 2013 Jun 07; 35(2):114-7. PubMed ID: 23828387 [Abstract] [Full Text] [Related]
12. Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins in colorectal cancers and their association with the CpG island methylator phenotype. Walsh MD, Clendenning M, Williamson E, Pearson SA, Walters RJ, Nagler B, Packenas D, Win AK, Hopper JL, Jenkins MA, Haydon AM, Rosty C, English DR, Giles GG, McGuckin MA, Young JP, Buchanan DD. Mod Pathol; 2013 Dec 07; 26(12):1642-56. PubMed ID: 23807779 [Abstract] [Full Text] [Related]
13. Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer. Rakha EA, Boyce RW, Abd El-Rehim D, Kurien T, Green AR, Paish EC, Robertson JF, Ellis IO. Mod Pathol; 2005 Oct 07; 18(10):1295-304. PubMed ID: 15976813 [Abstract] [Full Text] [Related]
14. Evaluation of MUC1, MUC2, MUC5AC, and MUC6 Expression Differences in Lung Adenocarcinoma Subtypes by Using a Final Immunoreactivity Score (FIRS). Buyuk M, Ozluk Y, Bakkaloglu DV, Ozkan B, Firat P, Yilmazbayhan D. Turk Patoloji Derg; 2023 Oct 07; 39(1):64-74. PubMed ID: 36367122 [Abstract] [Full Text] [Related]
15. Mucins in neoplastic spectrum of colorectal polyps: can they provide predictions? Molaei M, Mansoori BK, Mashayekhi R, Vahedi M, Pourhoseingholi MA, Fatemi SR, Zali MR. BMC Cancer; 2010 Oct 07; 10():537. PubMed ID: 20929551 [Abstract] [Full Text] [Related]
16. Notch3 signaling is associated with MUC5AC expression and favorable prognosis in patients with small intestinal adenocarcinomas. Eom DW, Hong SM, Kim J, Kim G, Bae YK, Jang KT, Yu E. Pathol Res Pract; 2014 Aug 07; 210(8):501-7. PubMed ID: 24810798 [Abstract] [Full Text] [Related]
17. Associations between the expression of mucins (MUC1, MUC2, MUC5AC and MUC6) and clinicopathologic parameters of human breast carcinomas. Oral O, Unverdi H, Kumcu E, Turkbey D, Dogan S, Hucumenoglu S. Indian J Pathol Microbiol; 2020 Aug 07; 63(4):551-558. PubMed ID: 33154304 [Abstract] [Full Text] [Related]
18. Immunohistochemical study of MUC1, MUC2 and MUC5AC in colorectal carcinoma and review of literature. Kesari MV, Gaopande VL, Joshi AR, Babanagare SV, Gogate BP, Khadilkar AV. Indian J Gastroenterol; 2015 Jan 07; 34(1):63-7. PubMed ID: 25731647 [Abstract] [Full Text] [Related]
20. Mucinous phenotype and CD10 expression of primary adenocarcinoma of the small intestine. Kumagai R, Kohashi K, Takahashi S, Yamamoto H, Hirahashi M, Taguchi K, Nishiyama K, Oda Y. World J Gastroenterol; 2015 Mar 07; 21(9):2700-10. PubMed ID: 25759539 [Abstract] [Full Text] [Related] Page: [Next] [New Search]